Late tissue effects following radiotherapy and neoadjuvant hormone therapy of the prostate measured with quantitative magnetic resonance imaging.
Affiliation
Imaging Science and Biomedical Engineering, University of Manchester, UK.Issue Date
2008-07
Metadata
Show full item recordAbstract
BACKGROUND AND PURPOSE: To use quantitative MRI to detect changes in the vascular and MR relaxation characteristics of the prostate gland 1 year after external beam radiotherapy. MATERIALS AND METHODS: Twenty-one patients underwent MRI before and after external beam radiotherapy for prostatic adenocarcinoma. Tracer kinetics analysis was applied to data from regions of interest in prostate tumour, normal prostate peripheral zone and muscle to obtain estimates of blood flow, extravascular-extracellular volume, blood volume and capillary permeability surface area product. T(1) and T(2) were also measured in these regions. RESULTS: Significant changes (p<0.05) after radiotherapy were found in all three tissues examined. Tumour blood flow was 0.34 and 0.14 ml (ml tissue)(-1) min(-1) before and after treatment, respectively, and T(1) increased from 922 to 1,070 ms. In normal peripheral zone, extravascular-extracellular volume increased from 0.21 to 0.52 ml (ml tissue)(-1), and T(2) decreased from 126 to 106 ms. In muscle, both permeability surface area product and T(2) rose, from 0.02 to 0.06 ml (ml tissue)(-1) min(-1) and from 50 to 56 ms, respectively. CONCLUSIONS: Quantitative MRI can be used to measure significant changes in both vascular and MR relaxation properties of the prostate and nearby muscle following treatment for prostate cancer using external beam radiotherapy.Citation
Late tissue effects following radiotherapy and neoadjuvant hormone therapy of the prostate measured with quantitative magnetic resonance imaging. 2008, 88 (1):127-34 Radiother OncolJournal
Radiotherapy and OncologyDOI
10.1016/j.radonc.2008.02.018PubMed ID
18342969Type
ArticleLanguage
enISSN
0167-8140ae974a485f413a2113503eed53cd6c53
10.1016/j.radonc.2008.02.018
Scopus Count
Collections
Related articles
- Prostate cancer: evaluation of vascular characteristics with dynamic contrast-enhanced T1-weighted MR imaging--initial experience.
- Authors: Buckley DL, Roberts C, Parker GJ, Logue JP, Hutchinson CE
- Issue date: 2004 Dec
- High-dose radiotherapy plus prolonged hormone therapy in CT2-3 prostatic carcinoma: is it useful?
- Authors: Cellini N, Pompei L, Fortuna G, Ammaturo MV, De Paula U, Luzi S, Mattiucci GC, Morganti AG, Digesù C, Rosetto ME, Palloni T, Petrongari MG, Gentile P, Deodato F, Valentini V
- Issue date: 2004 Mar-Apr
- The potential for normal tissue dose reduction with neoadjuvant hormonal therapy in conformal treatment planning for stage C prostate cancer.
- Authors: Yang FE, Chen GT, Ray P, Vaida F, Chiru P, Hamilton RJ, Spelbring D, Abellera M, Vijayakumar S
- Issue date: 1995 Dec 1
- Use of neoadjuvant and adjuvant therapy to prevent or delay recurrence of prostate cancer in patients undergoing radiation treatment for prostate cancer.
- Authors: Pisansky TM
- Issue date: 2003 Dec 29
- [Prostate cancer external beam radiotherapy].
- Authors: de Crevoisier R, Pommier P, Latorzeff I, Chapet O, Chauvet B, Hennequin C
- Issue date: 2016 Sep